ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Half-Percent NIH, NCI Budget Raise Is Not Enough, Advocates Say

December 19, 2014

CCOP Review Committee Member Objects To “Unwarranted Criticism”

March 4, 1988

CCOPs Payline Set At 211, Winners Lister; NCI Will Fund Only 51 Unless More Funds Added

March 16, 1990

Smokers May Get Cessation Help From Medicare.

January 14, 2005

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005